Navigation Links
Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh
Date:2/23/2011

NEW YORK, Feb. 23, 2011 /PRNewswire/ -- Stemline Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel oncology compounds that target cancer stem cells (CSCs), today announced that it holds the license, from the University of Pittsburgh ("Pitt"), for the exclusive worldwide rights to a clinically active oncology vaccine directed to multiple defined targets on tumor bulk and CSCs. Developed by Dr. Hideho Okada, Associate Professor of Neurological Surgery and his colleagues at Pitt, the vaccine demonstrated safety, tolerability, and anti-tumor activity as a single agent in a Phase I, National Institutes of Health-funded study conducted at Pitt in 22 participants with recurrent high-grade glioma.

According to Dr. Okada's research findings, published recently in the Journal of Clinical Oncology, the most common grade 1-2 adverse events (AEs) were injection site reactions and fatigue. There were no grade 3 or 4 AEs. The vaccine elicited immune responses in 81% of evaluable patients. A high rate of overall response and disease stabilization was observed in this heavily pre-treated population, including 46% (6/13) in glioblastoma (GBM), and 67% (6/9) in anaplastic glioma (AG). Notably, there was one durable complete response (CR) of greater than 12 months in a 1st salvage GBM patient, and one partial response (PR) of 7 months duration in a 2nd salvage GBM patient. In both cases, the vaccine induced tumor shrinkage as determined by MRI according to standard RECIST criteria. A survival improvement over historical data was also observed in both the recurrent GBM and AG populations. The vaccine and its derivatives are being developed by Stemline under the name SL-701 as both an "off-the-shelf" peptide vaccine and a dendritic cell (DC) vaccine.

Tom Cirrito, PhD, Director of Operations at Stemline noted, "We became interested in Pitt's vaccine because of its dual targeting of both tumor bulk and cancer stem cells. In addition, by virt
'/>"/>

SOURCE Stemline Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Stemline Therapeutics Announces Poster Presenting in vivo and Anti-Cancer Stem Cell Activity of SL-401 against Chronic Myeloid Leukemia (CML) at the 51st Annual Meeting of the American Society of Hematology (ASH)
2. Stemline Therapeutics CEO to Present at IBCs New Frontiers in Cancer Drug Development Conference
3. Reportlinker Adds Targeted Therapeutics- Advancement in Gene Therapy and Stem Cell Therapy will Drive the Market
4. Amicus Therapeutics Provides Positive Data Update from Phase 2 Long-Term Extension Study of Amigal™ for Fabry Disease
5. United Therapeutics Corporation Reports 2010 Fourth Quarter and Annual Financial Results
6. Chimerix Completes $45 Million Financing to Fund Further Development of Novel Antiviral Therapeutics CMX001 and CMX157
7. ViroPharma to Participate in the Leerink Swann Hot Topics in Therapeutics Roundtable Conference
8. Orexigen® Therapeutics Announces Corporate Realignment
9. Talecris Biotherapeutics Announces Teleconference and Webcast Information for Special Meeting of Shareholders
10. Talecris Biotherapeutics to Report Fourth Quarter and Full Year 2010 Financial Results
11. United Therapeutics Corporation to Announce Fourth Quarter and Annual 2010 Financial Results Before Market Open on Tuesday, February 15, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... IAC Industries wants to share with you the ... to set up and furnish a research lab knowing that ... a year’s time. How does a company make choices in ... What is efficient and cost-effective? , The solution was ... The planners at DisperSol determined that the concept of modular ...
(Date:5/16/2013)... Zealand (PRWEB) May 16, 2013 In late ... invited to speak to doctors in China about Appearance ... and NZ, this was her first trip to lecture in ... Hart visited Guangzhou and Fuzhou, home to 12 and 7 ... China is very high at this point in time. As ...
(Date:5/16/2013)... -- The registration deadline has been extended until May 22 ... Conference, the premier conference for bioscience financial officers. The ... San Diego Bayfront. "We are putting ... to make sure as many people as possible have ... , Chief Financial Officer of Mast Therapeutics, Inc. ...
(Date:5/16/2013)... May 16, 2013 Reportlinker.com ... report is available in its catalogue: ... Biomarkers for Acute Coronary Syndromes - ... http://www.reportlinker.com/p01182969/MediPoint-Diagnostic-Cardiac-Biomarkers-for-Acute-Coronary-Syndromes---APAC-Analysis-and-Market-Forecasts.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic ... Coronary Syndromes - APAC Analysis and ...
Breaking Biology Technology:New Downloadable Success Story: “How To Outfit a Dynamic Lab in Flux” 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 2MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 3MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 4MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 5MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 6MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 7MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts 8
... tracking solution now available,internationally, DENVER, Nov. ... (OTC Bulletin Board: GLOB), an international e-Health,medical ... a privately held healthcare consulting and software ... that they,have signed an agreement under which ...
... Iceland, November 4 deCODE,genetics (Nasdaq: DCGN ) ... before a Nasdaq Listing Qualifications Panel to present ... 4450(b)(1)(A), which,requires a minimum market value of listed ... received a Staff Determination Letter from The,Nasdaq Stock ...
... (Nasdaq:,ONTY) (TSX:ONY), a biotechnology company specializing in the ... cancer, today,announced that Robert Kirkman, M.D., President and ... Rodman & Renshaw Annual Global Investment,Conference in New ... 11:35 a.m.,E.T., A live and archived webcast ...
Cached Biology Technology:Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers 2Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers 3Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers 4Global Med Technologies(R), Inc. Partners With Biomedical Synergies to Offer Advanced Tissue Tracking Solutions for Hospitals and Surgery Centers 5deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter 2deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter 3deCODE Requests Hearing With Nasdaq Following Receipt of Staff Determination Letter 4
(Date:5/16/2013)... shown a gene involved in neurodegenerative disease also plays ... circadian clock. , In a study of the ... Ataxin-2, keeps the clock responsible for sleeping and waking ... of the fruit fly,s sleep-wake cycle is disturbed, making ... fly. , The discovery is particularly interesting because ...
(Date:5/16/2013)... PA, May 16, 2013 The relationship between ... (IQ) has not been clear. Schizophrenia is commonly ... disability. There are clues that reduced IQ may ... For example, reduced cognitive ability may precede the ... be present in healthy relatives of people diagnosed ...
(Date:5/16/2013)... extinct creature with ,scissor hand-like, claws in fossil records ... movie star. , The 505 million year old ... which is a distant ancestor of lobsters and scorpions, ... starring role as Edward Scissorhands - a movie about ... has scissors for hands. , Kooteninchela deppi ...
Breaking Biology News(10 mins):Gene involved in neurodegeneration keeps clock running 2Genetic risk for schizophrenia is connected to reduced IQ 2Actor Johnny Depp immortalized in ancient fossil find 2
... University of Florida researchers have identified a drug compound ... in a remarkable finding prevents damage to ... The findings, which appear in todays (May 1) ... lead to a new class of antihypertensive drugs designed ...
... May 2 & 3, 2008, the National Inventors Hall of ... honor for 2008 are the inventors such as Amar Bose ... created the LED, and chemist Ruth Benerito who discovered wrinkle-free ... Friday, May 2nd to honor this years deceased inductees, from ...
... BOZEMAN, Mont. -- Montana State University research about pollution ... of India, producing some optimism among MSU scientists who ... that our work is being recognized by a government ... level," said Steve Hamner, research associate in microbiology. "Lots ...
Cached Biology News:UF scientists discover compound that could lead to new blood pressure drugs 2UF scientists discover compound that could lead to new blood pressure drugs 3National Inventors Hall of Fame welcomes 2008 inductees 2Montana State University research reaches Supreme Court of India 2
... form from a hematopoietic stem cells called ... the bone surface and lowering the surrounding ... 4.5. The bone mineral is then solubilized ... function is controlled primarily by Macrophage Colony-Stimulating ...
... is critical to the maintenance of ... proteins as important and diverse as ... shock and stress response, antigen presentation, ... ion channels, cell cycle regulation, transcription, ...
... includes 1. Scanning of gel(s) 2. ... tryptic in-gel digestion and peptide extraction ... 5. Acquisition of PMF (Peptide Mass ... TOF/TOF) 6. Acquisition of PFF (Peptide ...
... The Vibratome Company has joined forces ... introduce the Vibratome 411301 Tissue Chopper. This ... prepare sections of tissue for metabolic experiments ... and irregular specimens available at biopsy or ...
Biology Products: